Clinica's Medtech Ventures - Issue 9: The parallels between venturing and parenting
This article was originally published in Clinica
UK technology development and innovation firm Cambridge Consultants has created over twenty new ventures in the past twenty five years, several of which have gone on to be listed on the London Stock Exchange or merged with a larger corporate partner. Between 1999 and 2004, the company's spin-out investments produced an internal rate of return (RII) of over 50%. In this article, Ray Edgson, Cambridge Consultants' chief technology officer and ventures director, looks at the key aspects of nurturing a business venture on the path to success.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.